Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04004806 · ClinicalTrials.gov registry record · NA
Tracking Device Guided Feedback to Enhance Patient Physician Interaction
A NA study of Burnout, Professional and Physician Patient Relation, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 239
- Enrollment target
- 1
- Study location
NCT04004806: Completed NA study of Burnout, Professional and Physician Patient Relation, sponsored by The Cleveland Clinic.
NCT04004806 is a NA study of Burnout, Professional and Physician Patient Relation that has completed, run by The Cleveland Clinic. The registered enrollment target is 239 participants, above the 198-participant average among 28 other Burnout, Professional trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04004806, a NA study of Burnout, Professional and Physician Patient Relation, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 239 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective cohort study aimed to determine the impact of increased physician patient interaction on physician well being and patient satisfaction. It involves recording time spent by physicians at the patient's bedside using tracking devices and providing feedback emails encouraging them to spend more time. The data will be analyzed to see if bedside time correlates with patient satisfaction scores. The study has 3 phases - 1. Observational phase for 3 months: Only involves recording baseline physician bedside time using tracking devices. 2. Interventional phase for 6 months involves generating percentile scores for physician bedside time and providing feedback through emails and texts. 3. Post intervention phase for 3 months to evaluate the impact of intervention on daily practice of physicians.
Primary Outcome
total number of minutes spent by each participant at a patient's bedside divided by the total number of patients
Conditions Studied
Interventions
- DEVICE Hill Rom tracking device
Study Locations (1)
Ohio
- Cleveland Clinic Main Campus - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2019-09-02 |
| Est. Completion | 2020-11-30 |
| Phase | NA |
What the finished NCT04004806 record still lists
NCT04004806 is an interventional study that assigns participants to a tested intervention. The registered 239 participants enrollment target is mid-sized for trials with a published cap, above the 198-participant average among 28 other Burnout, Professional trials with a reported enrollment target (21% higher).
The record links to 2 conditions, with Burnout, Professional appearing as the primary indexed condition, and to 1 intervention - of which Hill Rom tracking device is the first listed.
NCT04004806 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04004806 about?
NCT04004806 is a clinical study titled "Tracking Device Guided Feedback to Enhance Patient Physician Interaction". A prospective cohort study aimed to determine the impact of increased physician patient interaction on physician well being and patient satisfaction. It involves recording time spent by physicians at the patient's bedside using tracking devices and providing feedback emails encouraging them to spend...
What is the current status of trial NCT04004806?
This trial is currently completed. It is a NA study. The enrollment target is 239 participants. The study started on 2019-09-02. Estimated completion is 2020-11-30.
What conditions does trial NCT04004806 study?
This clinical trial studies the following conditions: Burnout, Professional, Physician Patient Relation.
What interventions are being tested in trial NCT04004806?
The interventions under investigation include: Hill Rom tracking device (DEVICE).
Who is sponsoring clinical trial NCT04004806?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04004806 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burnout, Professional
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04004806's enrollment target sits among peer trials
239 9th of 28 higher than 20 of 28 other Burnout, Professional trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Burnout, Professional trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Heart Rate Variability Modulation on Stress Management Among Physicians
RECRUITING · NA
-
Foundational Programs to Combat Clinician Stress
RECRUITING · NA
-
Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST)
RECRUITING · NA
-
Mastery Learning in Communication Skills
RECRUITING · NA
-
Supervision in Substance Use Disorder Treatment Programs
RECRUITING · NA
-
Feasibility Testing a Meditation App for Professionals Working With Youth in the Legal System
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI